CeeTox
Biotechnology ResearchMichigan, United States11-50 Employees
Contract Research Organization (CRO) CeeTox, Inc. leads the field of in vitro safety testing for the pharmaceutical, fragrance, personal care, cosmetic, chemical, and cleaning product industries. Worldwide demand to eliminate animal testing led CeeTox to adapt its robust, multi-parameter approach to meet the needs of cosmetic and chemical manufacturers. CeeTox has developed a range of in vitro screens that offer alternatives to animal tests in support of regulations such as REACH and Amendment 7 to the Cosmetics Directive. On January 1, 2014, the business and assets of CeeTox, Inc was acquired by the ADME-Tox Specialists, Cyprotex PLC (www.cyprotex.com) through its US subsidiary Cyprotex US, LLC (formerly Apredica, LLC). The acquisition will allow Cyprotex to expand their portfolio of services in the personal care, cosmetics and chemical industries, and customers of CeeTox will benefit from the extended range of ADME-Tox services currently offered by Cyprotex. For more information on the acquisition, visit: http://cyprotex.com/news/575/ CeeTox’s in vitro screens include: CTOX Panel Acute In Vitro Toxicity Screen Drug-Drug Interaction Toxicity Screen Cardiotox Panel Skin Irritation Skin Corrosion Percutaneous Absorption Phototoxicity Ocular Corrosion and Irritation Skin Sensitization Endocrine Disruption In Vitro Acute toxicity-LD50 Innovative science is just part of the picture when CeeTox scientists serve as an extension of your R&D team. We take the time to understand projects in depth and offer counsel. Our goal is to enable you to make key decisions quickly with confidence.
1-888-653-2347 
support@leadiq.com 
